MITOCHON PHARMACEUTICALS

Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Their development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrit... ion (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.

#SimilarOrganizations #People #Financial #Website #More

MITOCHON PHARMACEUTICALS

Social Links:

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2014-01-01

Address:

Radnor, Pennsylvania, United States

Country:

United States

Website Url:

http://www.mitochonpharma.com

Total Employee:

Status:

Active

Total Funding:

2.33 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress